Zainab Atiq

Researcher

University of Arkansas for Medical Sciences

unknown

4 h-index 8 pubs 36 cited

Research Areas

Links

Research Group

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Zainab Atiq's research activities include the study of cancer treatment modalities, particularly focusing on the intersection of chemotherapy and immunotherapy for pancreatic adenocarcinoma. She has also investigated the impact of pembrolizumab, examining its potential side effects such as distal renal tubular acidosis. A significant area of her work involves examining disparities in healthcare access and outcomes among specific patient populations, with a publication focusing on disparities among GU cancer patients referred to palliative care.

Atiq's scholarly contributions are reflected in her publication record and citation metrics. She has a h-index of 4 and has authored 8 publications with a total of 36 citations. Her collaborative network includes Osman O. Atiq from the University of Arkansas for Medical Sciences, with whom she shares one publication. Her recent activity indicates ongoing engagement in research.

Metrics

h-index: 4
Publications: 8
Citations: 36

Selected Publications

Disparities among GU cancer patients referred to palliative care. (2021) DOI
A case of pembrolizumab induced distal renal tubular acidosis (2021) DOI
A Case of Metastatic Pancreatic Adenocarcinoma in Complete Remission Using Chemotherapy and Immunotherapy (2021) DOI